retatrutide clinical trial results 2024 2025 press release Eli Lilly touts strong of new experimental weight loss drug New Obesity Drug Helped People

It can make your weight loss journey easier

After a year being off the medication only people who lost 15% or more of their body weight still retained meaningful weight loss. Its not just weight

People can lose weight with compounded GLP-1s

Retatrutide vs Tirzepatide Tirzepatide (Mounjaro/Zepbound) activates GLP-1 and GIP, offering more fat loss than semaglutide for many users

Medicare does cover GLP-1s for FDA-approved uses other than weight loss, including type 2 diabetes, reducing cardiovascular risk and obstructive sleep apnea

Starting at the full target dose would produce maximum GI effects immediately, reducing tolerability and potentially causing research subjects to discontinue